Oncotelic Therapeutics (OTLC) Accounts Payables (2010 - 2026)
Oncotelic Therapeutics (OTLC) reported Accounts Payables of $2.55 million for Q2 2026, up 2.7% from $2.49 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics posted Accounts Payables of $2.57 million, up 5.5% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- By year, Accounts Payables came in at $2.44 million in FY2024 (unchanged), $2.44 million in FY2023 (-2.9%), $2.51 million in FY2022 (-18.8%) and $3.09 million in FY2021 (+13.0%).
- Five-year quarterly Accounts Payables spans a low of $2.44 million in Q4 2024 and a high of $4.41 million in Q3 2021.
- Year over year, Accounts Payables gained in six of the last seven quarters, with growth averaging 2.2%.
- The high point for year-over-year Accounts Payables in five years was Q3 2021 (growth of 61.3%); the low point was Q3 2022 (a decline of 35.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 2.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Mn |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.93 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | 4.41 Mn |
| Jun 30, 2021 | 4.15 Mn |
API Access
Oncotelic Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();